|
STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
|
3 Months Ended | 6 Months Ended | 170 Months Ended | ||
|---|---|---|---|---|---|
|
Feb. 28, 2015
|
Feb. 28, 2014
|
Feb. 28, 2015
|
Feb. 28, 2014
|
Feb. 28, 2015
|
|
| Revenue | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet | $ 0us-gaap_SalesRevenueNet |
| Operating expenses: | |||||
| General and administrative | 1,675us-gaap_GeneralAndAdministrativeExpense | 1,724us-gaap_GeneralAndAdministrativeExpense | 3,383us-gaap_GeneralAndAdministrativeExpense | 3,601us-gaap_GeneralAndAdministrativeExpense | 50,602us-gaap_GeneralAndAdministrativeExpense |
| Professional fees | 8,773us-gaap_ProfessionalFees | 3,201us-gaap_ProfessionalFees | 8,773us-gaap_ProfessionalFees | 9,245us-gaap_ProfessionalFees | 208,775us-gaap_ProfessionalFees |
| Depreciation | 548us-gaap_DepreciationDepletionAndAmortization | 1,048us-gaap_DepreciationDepletionAndAmortization | 1,096us-gaap_DepreciationDepletionAndAmortization | 2,096us-gaap_DepreciationDepletionAndAmortization | 22,056us-gaap_DepreciationDepletionAndAmortization |
| Total operating expenses | 10,996us-gaap_OperatingExpenses | 5,973us-gaap_OperatingExpenses | 13,252us-gaap_OperatingExpenses | 14,942us-gaap_OperatingExpenses | 281,433us-gaap_OperatingExpenses |
| Net Operating Loss | (10,996)us-gaap_OperatingIncomeLoss | (5,973)us-gaap_OperatingIncomeLoss | (13,252)us-gaap_OperatingIncomeLoss | (14,942)us-gaap_OperatingIncomeLoss | (281,433)us-gaap_OperatingIncomeLoss |
| Other income (expense): | |||||
| Interest expense | (7,752)us-gaap_InterestExpense | (7,859)us-gaap_InterestExpense | (12,253)us-gaap_InterestExpense | (13,283)us-gaap_InterestExpense | (112,856)us-gaap_InterestExpense |
| Offering costs | 0us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts | 0us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts | 0us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts | 0us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts | (13,000)us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts |
| Total other expense | (7,752)us-gaap_OtherNonoperatingIncomeExpense | (7,859)us-gaap_OtherNonoperatingIncomeExpense | (12,253)us-gaap_OtherNonoperatingIncomeExpense | (13,283)us-gaap_OtherNonoperatingIncomeExpense | (125,856)us-gaap_OtherNonoperatingIncomeExpense |
| Loss before provision for income taxes | (18,748)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (13,832)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (25,505)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (28,225)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | (407,289)us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments |
| Provision for income taxes | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit | 0us-gaap_IncomeTaxExpenseBenefit |
| Net income (loss) | $ (18,748)us-gaap_NetIncomeLoss | $ (13,832)us-gaap_NetIncomeLoss | $ (25,505)us-gaap_NetIncomeLoss | $ (28,225)us-gaap_NetIncomeLoss | $ (407,289)us-gaap_NetIncomeLoss |
| Net income (loss) per share - basic (in Dollars per share) | $ 0.00us-gaap_EarningsPerShareBasic | $ 0.00us-gaap_EarningsPerShareBasic | $ 0.00us-gaap_EarningsPerShareBasic | $ 0.00us-gaap_EarningsPerShareBasic | |
| Net income (loss) per share - diluted (in Dollars per share) | $ 0.00us-gaap_EarningsPerShareDiluted | $ 0.00us-gaap_EarningsPerShareDiluted | $ 0.00us-gaap_EarningsPerShareDiluted | $ 0.00us-gaap_EarningsPerShareDiluted | |
| Weighted average shares outstanding - basic (post-reverse split) (in Shares) | 37,581,903us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 31,358,903us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 37,581,903us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | 31,358,903us-gaap_WeightedAverageNumberOfSharesOutstandingBasic | |
| Weighted average shares outstanding - diluted (post-reverse split) (in Shares) | 37,581,903us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 31,358,903us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 37,581,903us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | 31,358,903us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding | |
| X | ||||||||||
|
- Definition
Represents the charge against earnings during the period for commitment fees and debt issuance expenses. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|